How many investments has Schooner Capital made?

Schooner Capital has 32 tracked investments, 3 of which have exited via acquisition or IPO, including 5 dated in the last 24 months.

What stage does Schooner Capital invest at?

Schooner Capital invests at the Seed, Late Stage stages.

What sectors does Schooner Capital focus on?

Schooner Capital focuses on Sector Agnostic.

Where is Schooner Capital located?

Schooner Capital is headquartered in Boston, US.

Does Schooner Capital lead rounds?

Schooner Capital has led 3 of the 5 rounds where its role is on record.

Who does Schooner Capital co-invest with?

Schooner Capital most often shares deals with 20/20 HealthCare Partners LLC, Lifeforce Capital, Collaborative Fund, among 82 tracked co-investors.

Schooner Capital

Crossover fund

Boston · Seed–Late Stage · 16 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Schooner Capital operates from a permanent, evergreen capital base, investing in both private companies and public securities. It looks across sector, stage and geography, emphasizing independent judgment and contrarian thinking. With a patient approach developed over 55 years, the firm often invests multiple times in its holdings and favors deep, long-term partnerships with strong teams. Its evergreen structure and entrepreneurial roots let it respond to opportunities without mandate constraints or fundraising pressures. Profits support The Schooner Foundation, which is engaged in human rights causes globally.

Invests inSector AgnosticBoston Global

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Late Stage

Boston, US

Instruments

Equity

Founded

1971

Last 12 months

4 investments

Tracked investments

Team · 16 people

from the firm's website

Julia Pettengill· Executive Director of the Schooner Foundation· Boston, Massachusetts, United Statesin

Julia Pettengill is Executive Director of the Schooner Foundation, where she directs global grantmaking and operations across more than eighty partnerships in areas including human rights, global health equity, mental health, education, and environmental resilience. She has developed and managed philanthropic funds such as the Foundation's crisis response fund and global mental health portfolio. She holds a Bachelor of Arts and a Master of Education from the University of Cape Town.

Vin Ryan· Founder and Chairman

Vin Ryan founded Schooner in 1971 and has led the firm for over five decades. He purchased and grew Iron Mountain, a global records management company, serving as its director from 1971 to 2015, and was a director and investor in Continental Cablevision for more than two decades until its 1996 sale. He also founded National Hydro and Arch Mobile Communications, established The Schooner Foundation in 1996, and is a graduate of Boston University.

Alexandra Manick· Managing Directorin

Alex Manick is a Managing Director at Schooner Capital who works on venture and growth investments. She holds a BS in Materials Science from MIT and an MBA from Stanford, and earlier worked at MIT spin-out 1366 Technologies. She currently sits on the boards of several portfolio companies and previously served as a director at Jetcool Technologies before its acquisition by Flex.

Antonio Cienfuegos· Managing Directorin

Antonio Cienfuegos joined Schooner Capital in 2014 and serves as a Managing Director focused on the firm's direct public equity investment efforts, which he helped launch and manage. He works on investment identification, due diligence, valuation, portfolio construction and trading for the public equities portfolio across US and global markets, and also provides corporate finance and strategic support across the broader portfolio. He holds dual degrees in Financial Economics and Hispanic Studies from Columbia University.

Brian Rodgers· Controllerin

Brian Rodgers joined Schooner Capital in 2010 and became its Controller in 2023, where he works on internal financial matters and tax preparation. Before Schooner, he spent three years in public accounting at Tonneson & Company CPA's P.C. handling attestation and tax engagements. He holds an undergraduate degree and a Master's of Accounting from the University of New Hampshire and is a licensed CPA in Massachusetts.

Carl Becker· Associatein

Carl Albrecht Becker is an Associate at Schooner Capital working on venture and growth investments. Before joining the firm, he was a Consultant at Bain & Company and held roles at startups and larger companies including Volkswagen and Deutsche Telekom. He earned a BSc and MSc in Business Administration and Electrical Power Engineering from RWTH Aachen University and an MBA from MIT Sloan.

Chan Won· Analystin

Chan Won is an Analyst at Schooner Capital working on public equity investment opportunities, supporting the process from idea generation through diligence, valuation, and execution, as well as portfolio monitoring. He joined the firm after graduating from New York University with dual degrees in Finance and Data Science. Before Schooner, he was the sole analyst at a consumer-focused public equity fund and a summer associate in Temasek's investment group.

Isabel Vinson· Operations Associatein

Isabel Vinson is an Operations Associate at Schooner Capital and the Schooner Foundation, where she oversees day-to-day operations and serves as the firm's benefits administrator. At the foundation, she works with the Executive Director on the internship program, communications, and operations. She holds a Bachelor of Arts in Political Science and French, with minors in Criminal Justice and European Studies, from the University of Wisconsin-Madison.

Jon Corbett· Managing Director and Chief Financial Officerin

Jon Corbett is Managing Director and CFO of Schooner Capital, named to the CFO role in 2024 after serving as VP Finance from 2018 and Controller from 2011. He oversees Schooner's accounting, finance operations, and tax compliance, supports its public equities efforts, and works with several private portfolio companies, including a directorship at SRS Medical. Before Schooner, he spent over a decade in public accounting at Tonneson + Co, holds a business degree from Merrimack College and a Master of Science in Taxation from Bentley University, and is a CPA in Massachusetts.

Laurie Finkielsztein· Senior Associatein

Laurie Finkielsztein is a Senior Associate at Schooner Capital, working on early and growth stage investments. Before Schooner, she was on the investment team at Fifth Wall and started her career in investment banking within the TMT group at Goldman Sachs. She holds a degree in Computer Science from Brown University.

Lou Stathis· Staff Accountant

Lou Stathis joined Schooner Capital in 2005 as a staff accountant, handling accounts receivable, accounts payable, general ledger, and payroll. He previously worked as an accountant for the Boston Red Sox Baseball Club. He holds a degree from the University of Massachusetts' School of Management with a concentration in accounting.

Orhan Gazelle· Managing Directorin

Orhan Gazelle is a Managing Director at Schooner Capital, where he works on early and growth stage investments. He has held board roles at several SaaS companies and other firm holdings. He earned a Master of Engineering Management from Dartmouth College's Thayer School of Engineering and a BS with Honors in Mechanical Engineering from Trinity College.

Peter Binas· Chief Investment Officer, Managing Partnerin

Peter Binas is Schooner Capital's Chief Investment Officer and a Managing Partner, where he leads the firm's global direct public equity investing program and has worked across its private and public investing efforts for over fifteen years, including helping the firm return to direct investing. Before joining Schooner, he spent nearly ten years at McKinsey & Company. He holds a joint JD/MBA from Harvard Law School and Harvard Business School, where he was a Baker scholar, and earned an AB in Economics and Social Studies from Harvard University.

Rachel Billings in

Rachel Billings joined Schooner Capital in 2011 as executive assistant to the chairman and oversaw the Foundation from 2013 to 2018. Before that, she worked as a legislative specialist at InstaTrac, a Massachusetts legislation tracking web service. She attended the University of Massachusetts Amherst.

Solita Im· Accounting and Tax Managerin

Solita Im is an Accounting and Tax Manager at Schooner Capital, where she handles internal accounting, tax compliance, and reporting. Before joining the firm, she spent more than nine years in public accounting at Tonneson & Company and PricewaterhouseCoopers, working on tax matters for clients including high-net-worth individuals, partnerships, trusts, and private foundations. She earned a B.S. in Corporate Finance & Accounting and an M.S. in Taxation from Bentley University and is a CPA licensed in Massachusetts.

Ted Henderson· Chief Executive Officer, Managing Partner

Ted Henderson is Chief Executive Officer and a Managing Partner at Schooner Capital, where he focuses on internal management and firm strategy and has led the firm's return to direct investing over several decades, primarily in venture-stage companies. He serves as a director at Brixton Biosciences and SRS Medical. He holds an MBA from Harvard Business School and graduated cum laude from Dartmouth College, where he studied Mandarin.

What they invest in

from 30 of 33 portfolio companies

SaaS ×11Biotech ×8Healthtech ×8AI & Machine Learning ×5Cloud Computing ×4Deep Tech ×4Medical Devices ×4Digital Health ×3

HQs:United States×16Canada×1Ireland×1

Who they back

founder profiles across 12 portfolio companies

58%

solo founders

7 of 12 mapped founding teams

Founding team size:solo founder×72 founders×33 founders×14+ founders×1

Investments · 33 tracked

founders shown can be your intro path

By year:2026 · 4 2025 · 2 2023 · 2 2020 · 19 dated

Cartesian Therapeutics (NASDAQ: RNAC)cartesiantherapeutics.com in 𝕏NASDAQ: RNAC

Cartesian Therapeutics is a clinical-stage biotechnology company developing mRNA-based cell therapies aimed at treating autoimmune diseases.

BiotechHealthtechWatertown, US

Metin Kurtoglu(Executive Officer)Chris Jewell(Executive Officer)Carsten Brunn(President, CEO & Chairman of the Board)inEmily English(Executive Officer)Blaine Davis(Executive Officer)Stephen Smolinksi(Executive Officer)

Co-investorsK2 HealthVentures Maryland TEDCO TEDCO Polaris Partners

4G Clinical4gclinical.com in

4G Clinical builds randomization and trial supply management (RTSM) technology for complex clinical trials, serving biotech, biopharma, and CRO sponsors.

BiotechDigital HealthSaaSDover, US

Edward Tourtellotte(Executive Officer)David Kelleher(CEO)

Amplified Industriesamplified.industries in 𝕏Mar 2025

Amplified Industries builds wireless sensors and an AI-driven platform for monitoring and optimizing oilfield assets, offering well data capture, pump diagnostics (DynaCard/PumpCard), remote pump-off control, and spill and leak prevention.

AI & Machine LearningEnergyIoTBoston, US

Sebastien Mannai(Executive Officer, Director)Charles-Henri Clerget(Executive Officer, Director, Promoter)

BoardWilliam Severns(Director)Alexandra Manick(Director)

Co-investorsArgon Ventures SBXi

Bentobento.net in 𝕏

Bento operates a dental benefits platform that lets employers, associations, and health plans offer self-insured, customizable dental and vision plans with transparent pricing and AI-enabled real-time claim adjudication.

HealthtechInsurTechSaaS

Ram Sudireddy(CEO & Founder)in

Co-investorsCompanyon Ventures York IE

Bestdoctorsbestdoctors.com in 𝕏acquired by Teladoc Health

Digital HealthHealthtechMental Health

Breezewaybreezeway.ioMar 2026

AI-driven task management software for property managers

Boston, US

Jeremiah Gall(Executive Officer, Director)Jeremy Gall(Founder)in

BoardEd Walters(Director)Jeremiah Doyle(Director)Orhan Gazelle(Director)Simon Lehmann(Director)

Co-investorsCatalyst Investors Krillion Ventures LaunchCapital Tamarisc Ventures

Brixtonbiobrixtonbio.com

Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration.

BiotechMedical Devices

Charles Sidoti(Founder)in

Co-investorsAngel Physicians Fund Excelestar Ventures FemHealth Ventures SV Health Investors

Capitalprovisionscapitalprovisions.com

Capital Provisions provides office break room and unattended retail services including vending machines, micro markets, coffee, water, and pantry service, using logistics and inventory management technology.

FoodTechLogistics & Supply ChainRetail Tech

Carecubescarecubes.com inMar 2026 · $6.5M

Carecube is a medical device developed for hospitals, emergency responders, and care settings to support infectious disease response and preparedness.

HardwareHealthtechMedical Devices

Co-investorsLifeforce Capital Very Serious Ventures

Censinetcensinet.com in

Censinet provides a risk management platform for the healthcare industry that connects vendors, products, AI technologies, and internal operations to the clinical and business functions they support.

CybersecurityHealthtechSaaSBoston, US

Co-investorsBallad Ventures Excelerate Health Ventures HLM Venture Partners MemorialCare Innovation Fund Excel Venture Management LRVHealth

Commonwealth Fusion Systemscfs.energy in 𝕏May 2020

Commonwealth Fusion Systems develops commercial fusion power plants using high-temperature superconducting magnet technology to provide grid-scale energy.

CleantechClimate TechDeep TechEnergyCambridge, US

Brandon Sorbom(Founder)Robert Mumgaard(Executive Officer, Director)Daniel Brunner(Executive Officer)Bob Mumgaard(Founder)in

BoardMassimiliano Pieri(Director)Katie Rae(Director)in

Co-investorsAdvection Growth Capital Armada Investment AG Bay Bridge Ventures Climate Beni Venture Capital Brainstorm Ventures Breakthrough Energy Ventures +38 more

Congruity360congruity360.com in

Congruity360 provides unstructured data management and governance software for enterprises managing large, dispersed datasets across multiple storage systems.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareFall River, US

Co-investorsFlow Capital G20 Ventures

Crunchtimecrunchtime.com inAug 2026 · $80M

Crunchtime provides restaurant operations management software for multi-unit and enterprise restaurant brands, covering inventory management, labor and scheduling, operations execution, learning and development, and kitchen management.

AI & Machine LearningEnterprise SoftwareFoodTechSaaSSan Francisco, US

Co-investorsBattery Ventures Golub Growth DERIVE VENTURES Osage Venture Partners Ten Coves Capital

Cullinan Oncologycullinanoncology.com in 𝕏

Cullinan Therapeutics develops clinical-stage T cell engager therapies targeting autoimmune diseases and cancer, leveraging immune modulation expertise to advance high-impact therapeutic candidates.

BiotechDigital Health

Co-investorsLAV Lilly Asia Ventures MPM BioImpact Taiho Ventures, LLC

Emerald Cloud Labemeraldcloudlab.com in

Emerald Cloud Lab (ECL) provides remote, cloud-based access to a life science research laboratory, letting researchers run and automate experiments and workflows without a physical lab.

BiotechCloud ComputingDeep Tech

Brian Frezza(Founder)inD.J. Kleinbaum(Founder)in

Co-investorsBlue Ivy Ventures Gigafund Soundproof Ventures Founders Fund OS Fund

JetCooljetcool.com in 𝕏Oct 2023 · $17M

JetCool builds single-phase, direct-to-chip liquid cooling modules using its microconvective cooling technology to manage heat in high-power electronics such as data center servers, high-performance computing systems, and semiconductors.

CleantechHardwareSemiconductorsLittleton, US

Bernard Malouin Jr.(Executive Officer, Director)Jordan Mizerak(Cofounder)Alexandra Manick(Director)Lawrence Fish(Director)

Co-investorsBosch Ventures MassVentures Robert Bosch Venture Capital In-Q-Tel Raptor Group

Kewazokewazo.com in

KewaZo builds construction automation technology, including robotic systems for material transport at industrial and construction sites, aimed at reducing crane time and improving safety.

Construction TechHardwareRobotics

Ekaterina Grib(Founder)inArtem Kuchukov(Founder)inLeonidas Pozikidis(Founder)in

Co-investorsBenson Capital Chevron Technology Ventures Cybernetix Ventures Fifth Wall Gaingels Mana Ventures +1 more

Kythera Biopharmaceuticalsallergan.comAcquired

Aesthetic-medicine biopharma behind KYBELLA (deoxycholic acid) injection, acquired by Allergan in 2015 for ~$2.1 billion.

Co-investorsAisling Capital ARCH Venture Partners Prospect Venture Partners ALTITUDE LIFE SCIENCE VENTURES Foley Ventures Invus

Mannamanna.aeroApr 2026 · $50M

Manna operates an air delivery service using drone technology to deliver medical equipment, food, and other goods, with plans to reduce traffic and improve air quality in urban areas.

Deep TechLogistics & Supply ChainMobility & Transportation

Bobby Healy(Founder)in

Co-investorsFrontline Ventures Molten Ventures Radius Capital Ventures Tapestry VC Ireland Strategic Investment Fund

MarginEdgemarginedge.com in 𝕏

MarginEdge builds a restaurant management platform that handles invoice processing, inventory, cost tracking, and accounting integrations for restaurant operators.

FintechFoodTechSaaSArlington, US

Roy Phillips(Co-founder, Client Services)Bo Davis(Co-founder & CEO)Brian Mills(Co-founder & CTO)Emma Whelan(Chief Financial Officer)Jess Finnefrock(Chief Operating Officer)Tara Clever(Chief Revenue Officer)

Co-investorsBranded Strategic Hospitality Connetic Ventures DERIVE VENTURES IrishAngels Osage Venture Partners Ten Coves Capital

Mediasilomediasilo.com in 𝕏

MediaSilo is a cloud platform for managing, securing, and collaborating on video production assets.

Cloud ComputingMedia & EntertainmentSaaS

PartnerTed Henderson· led

Meilimeili.travel

Meili is a cloud-based platform that connects airlines and travel brands directly with car rental, accommodation, and mobility companies to distribute ancillary products (car rental, hotels, transfers) within booking flows.

Mobility & TransportationSaaSTravel & Hospitality

Millstonemedicalmillstonemedical.com

Co-investorsArlington Capital Partners

Mimetogenmimetogen.com

Mimetogen Pharmaceuticals is a late-stage clinical biotechnology company developing synthetic neurotrophin mimetics to treat ocular surface and retinal diseases.

BiotechMedical DevicesMontreal, CA

Onebeatonebeat.co in 𝕏May 2025 · $15M

Onebeat is a retail inventory intelligence platform that converts retail data into demand-based recommendations, helping retail teams reduce stock shortages and excess inventory while keeping stock aligned with real demand.

AI & Machine LearningRetail TechSaaS

Co-investorsAnD Ventures Magenta Venture Partners Surround Ventures

Ottometricottometric.com in 𝕏Jan 2023 · $10M

Ottometric provides a cloud-based data platform for developing driver-assistance and autonomous vehicle systems, automating validation workflows and transforming test data into actionable insights for automotive OEMs and suppliers.

AI & Machine LearningData & InfrastructureSaaSWaltham, US

John Curran(Executive Officer)Joseph Burke(Executive Officer, Director)inNick Pandher(Executive Officer)

BoardOrhan Gazelle(Director)inRich Redelfs(Director)inZenas Hutcheson(Director)in

Co-investorsRally Ventures Management, Llc Huntington Angels Network Proeza Ventures PS27 Ventures Trucks VC Somersault Ventures

Railcommrailcomm.com in 𝕏

Tracsis (formerly RailComm) develops software-based rail automation solutions including computer aided dispatching, positive train control, yard automation, and remote condition monitoring.

Logistics & Supply ChainMobility & TransportationSaaS

PartnerPeter Binas· led

Remedy Planremedyplan.com in

Remedy Plan is a biopharmaceutical company developing drugs that target NAMPT, an essential enzyme dysregulated in more than 20 diseases including cancer.

BiotechHealthtechRockville, US

Gregory Plan Crimmins(Executive Officer, Director)

Co-investors20/20 HealthCare Partners LLC

Seventhgenerationseventhgeneration.com in

Seventh Generation makes plant-based household cleaning products, including dish soaps, laundry detergents, all-purpose cleaners, and disinfectants formulated with biobased and botanical ingredients.

Circular EconomyConsumerImpact & Social Good

Co-investorsRenewal Funds

Spottedriskspottedrisk.com in

SpottedRisk offers insurance, bonding, and lending products tailored to the film and television production industry, working with producers and production companies.

FintechInsurTechMedia & Entertainment

Co-investorsBantam Group

Srsmedicalsrsmedical.com

SRS Medical develops treatments addressing urinary symptoms caused by enlarged prostates in aging men, with a focus on preserving and restoring bladder function.

HealthtechMedical Devices

Wavebreaktxwavebreaktx.com in

Wavebreak is a biotech company developing a drug discovery platform that uses biophysics to target transient toxic protein oligomers in amyloid disease pathways with small-molecule drugs.

BiotechDeep TechHealthtech

Co-investorsLifeforce Capital

Zixizixi.com in 𝕏acquired by Clearhaven Partners

Zixi provides software for reliable video delivery over unpredictable IP networks, using patented hitless failover, multi-path bonding, and adaptive error correction to recover from packet loss.

Cloud ComputingMedia & EntertainmentSaaS

PartnerTed Henderson· led

Co-investors20/20 HealthCare Partners LLC

Exits · 3

IPOs and acquisitions across the tracked portfolio

Cartesian Therapeutics (NASDAQ: RNAC)NASDAQ: RNACBestdoctorsacq. by Teladoc HealthZixiacq. by Clearhaven Partners

Portfolio news

latest coverage across their companies

MarginEdge Raises $80 Million Series D As Platform Processes $28 Billion In Restaurant Purchasing

MarginEdge · pulse2.com · Aug 21, 2026

MarginEdge Raises $80 Million as Competition for the AI-Powered Restaurant Back Office Intensifies |

Crunchtime · restauranttechnologynews.com · Aug 13, 2026

Fusion power darling Commonwealth Fusion Systems raises another $1B

Commonwealth Fusion Systems · techcrunch.com · Jul 30, 2026

Cullinan Oncology stock hits 52-week high at $17.97 By Investing.com

Cullinan Oncology · investing.com · Jun 23, 2026

Data center liquid cooling startup JetCool raises $17m - DCD

JetCool · datacenterdynamics.com · Jun 18, 2026

Carecubes Appoints New CEO Following Series A Funding and Market Expansion - TipRanks.com

Carecubes · tipranks.com · Jun 3, 2026

Lion Group inks MOU with Meili Capital to explo... | Pluang – Crypto, Stocks, Gold & Funds

Meili · pluang.com · May 28, 2026

Ireland's Manna secures $50M to scale US drone deliveries

Manna · dronedj.com · Apr 7, 2026

Frequently asked questions

How many investments has Schooner Capital made?: Schooner Capital has 32 tracked investments, 3 of which have exited via acquisition or IPO, including 5 dated in the last 24 months.
What stage does Schooner Capital invest at?: Schooner Capital invests at the Seed, Late Stage stages.
What sectors does Schooner Capital focus on?: Schooner Capital focuses on Sector Agnostic.
Where is Schooner Capital located?: Schooner Capital is headquartered in Boston, US.
Does Schooner Capital lead rounds?: Schooner Capital has led 3 of the 5 rounds where its role is on record.
Who does Schooner Capital co-invest with?: Schooner Capital most often shares deals with 20/20 HealthCare Partners LLC, Lifeforce Capital, Collaborative Fund, among 82 tracked co-investors.

Similar investors

83North

83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.

$100K – $10M

8VC

8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.

$100K – $50M

Accel

Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.

$1.6M – $70M

AirTree Ventures

AirTree Ventures runs Pathfinders, a free four-week in-person program in Sydney for young builders (high-school graduates up to age 23) to work on a real product, access the AirTree team and founders, and build a peer network.

$132K – $16.5M

Andreessen Horowitz

Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.

$500K – $50M